Controlled Release Drug Delivery Market Share

North America industry is expected to account for largest revenue share by 2037, driven by prevailing diseases related to gastrointestinal disorders, advancement in the technological infrastructure of pharmaceutical industry, along with increasing activities of research & development. The increase in the number of gastrointestinal patients will result in the rise in demand for controlled release drug delivery technology. The Asia Pacific market is predicted to be rapidly growing on the back of increase in geriatric and paediatric population in the region, rising demand for the controlled release drugs dosage over the forecast period.